what are glp 1 drugs derived from Discovery of GLP-1–Based for the Treatment of Obesity Designing GLP-1 delivery: structural perspectives

Macromolecule Content Total Structure Weight: 47.66 kDa Atom Count: 3,849 Modeled Residue Count: 418 Deposited Residue Count: 420 Unique protein chains: 1 Experimental Data Method: X-RAY DIFFRACTION Resolution: 1.60 R-Value Free: 0.227 (Depositor), 0.222 (DCC) R-Value Work: 0.195 (Depositor), 0.189 (DCC) R-Value Observed: 0.196 (Depositor) Unit Cell : Software Package: Deposition Data Released Date: 2009-04-21 Deposition Author(s): Parker, L.J

GLP-1 receptor agonist discontinuation among patients with obesity and/or type 2 diabetes

The samples were resolved on a 1015% polyacrylamide gel and scanned on a Typhoon variable mode imager or on a FluorChem M System (ProteinSimple, San Jose, CA, USA)

Is this product FDA-approved